2020
DOI: 10.1186/s40792-020-00986-8
|View full text |Cite
|
Sign up to set email alerts
|

Malignant phyllodes tumor of the breast with rapid progression: a case report

Abstract: Background Malignant phyllodes tumors (PTs) of the breast occur infrequently and are difficult to treat with adjuvant therapy. Here, we present a case of a female patient with a huge malignant PT with rapid progression in a short period. Case presentation A 44-year-old woman presented to our hospital with a rapid growth mass in her right breast, measuring 20 cm. She was initially diagnosed as having a borderline phyllodes tumor by core needle biopsy and underwent total mastectomy and artificial dermis was gra… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
19
0

Year Published

2021
2021
2022
2022

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 13 publications
(19 citation statements)
references
References 18 publications
0
19
0
Order By: Relevance
“…Its distinguishing characteristic is rapid growth. PT usually affects middle-aged women, with a mean age of 45 years [ 2 ]. PT may contain foci of benign, borderline, and malignant features intermixed within the same neoplasm.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Its distinguishing characteristic is rapid growth. PT usually affects middle-aged women, with a mean age of 45 years [ 2 ]. PT may contain foci of benign, borderline, and malignant features intermixed within the same neoplasm.…”
Section: Discussionmentioning
confidence: 99%
“…PT may contain foci of benign, borderline, and malignant features intermixed within the same neoplasm. A malignant component is differentiated from borderline tumors by marked stromal cellularity, stromal overgrowth, nuclear pleomorphism, and high mitotic activity [ 2 , 8 ].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Margin-negative resection combined with adjuvant radiotherapy is very effective for local control and prevention of recurrence [6]. Adjuvant chemotherapy is not the standard care since it is of controversial value for malignant phyllodes tumors, yet some institutions support doxorubicin-based adjuvant chemotherapy for rst-line treatment of breast sarcomas, especially with > 5.0 cm large high-risk tumors [22][23]. During postoperative follow-up, no local recurrence or distant metastasis were found.…”
Section: Discussionmentioning
confidence: 99%
“…Phyllodes tumors (PTs) of the breast, also referred to as cystosarcoma phyllodes, adenomatous myxoma, and pseudosarcoma adenoma [1], are rare fibroepithelial tumors composed of epithelial and cellular stromal components [1,2]. PT accounts for less than 1% of all diagnosed breast neoplasms in the world [2].…”
Section: Introductionmentioning
confidence: 99%